A randomized, placebo‐controlled crossover trial of phentermine‐topiramate ER in patients with binge‐eating disorder and bulimia nervosa

Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa

(2018) Shebani Sethi Dalai et al.   Contemporary Clinical Trials

Psychological status and weight variability over eight years: Results from Look AHEAD.

(2018) Carly R. Pacanowski et al.   HEALTH PSYCHOLOGY

Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial

(2016) Anna I. Guerdjikova et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Temperamental factors in severe weight cycling. A cross-sectional study

(2015) Martina de Zwaan et al.   APPETITE

Efficacy and Safety of Lisdexamfetamine for Treatment of Adults With Moderate to Severe Binge-Eating Disorder

(2015) Susan L. McElroy et al.   JAMA Psychiatry

Addiction potential of phentermine prescribed during long-term treatment of obesity

(2013) E J Hendricks et al.   INTERNATIONAL JOURNAL OF OBESITY

Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults

(2013) Louis J. Aronne et al.   Obesity

Fixed-dose combination of phentermine–topiramate for the treatment of obesity

(2013) Bruno Halpern et al.   Expert Review of Clinical Pharmacology

Topiramate Treatment Improves Hypothalamic Insulin and Leptin Signaling and Action and Reduces Obesity in Mice

(2012) Andrea M. Caricilli et al.   ENDOCRINOLOGY

Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review

(2008) Beatriz Arbaizar et al.   GENERAL HOSPITAL PSYCHIATRY